News
Article
Author(s):
Dermatology Times is looking back on the top stories in dermatology that involve strides in skin health equity: addressing disparities for skin of color, women, LGBTQ+ patients, and improving care access.
Dermatology Times reflects on the strides made over the past year in advancing skin health equity. From addressing disparities in care for skin of color, women, and LGBTQ+ patients to improving access for underserved populations, we explore the progress, challenges, and advocacy shaping a more inclusive future in dermatology in 2024.
Miranda Uzoma Ewelukwa, MD, FAAD, reviewed how skin of color representation has evolved in dermatology, however, more advocacy is still needed.
Researchers involved in the review said this increase may help lead to more patient education and more tailored products for patients from this region.
Adamson shared with Dermatology Times about the significance of Vaseline's Mended Murals initiative and the role of dermatologists in improving patient access.
Susan Taylor, MD, believes in training more investigators that serve diverse populations to enhance clinical trials. Here are a few resources to get started in clinical trials.
Dermatology Times spoke with 5 women clinicians in the field on International Women's Day to discuss the influences and advice that brought them to where they are today.
New data was presented at the American Academy of Dermatology Annual Meeting in San Diego, California.
In celebration of Women's History Month and International Women's Day, dermatologist Nicole Negbenebor, MD, discussed her journey in the dermatology space and provided advice for young women and girls aspiring to enter the medical field.
A vote during the annual meeting will keep DEI initiatives in place and members are awaiting news on what those initiatives will look like.
The Bristol Myers Squibb-hosted event brought together a panel of leading women in dermatology to discuss the challenges they’ve faced and how women can support each other.
Dermatology Times spoke with Latanya Benjamin, MD, FAAD, FAAP, the newly-appointed president of the WDS, to discuss her hopes and goals for her presidency.
Spizuoco shares pearls from her sessions, "Infectious Diseases: The Story Behind STDs," and "Everything You Need to Know About Dermatopathology and the Dermatopathologist," from the Diversity in Dermatology conference.
Researchers from Google and Stanford Medicine partnered to develop the Skin Condition Image Network dataset, a tool aimed at providing image resources for conditions across skin tones.
Shahriari shared pearls and considerations from her sessions at the recent Diversity in Dermatology conference.
In a literature review, researchers found data supporting the efficacy and safety of fillers in patients with skin of color, particularly for populations where is there is limited data.
Addressing gender inequity in academic dermatology involves strengthening societies, celebrating female dermatologists, promoting leadership, and equitable representation, authors wrote.
LC-OCT provided quick, noninvasive assessment of skin conditions with detailed imaging aids diagnosis and treatment, especially for patients with darker skin types.
A survey covered topics including skin-aging prevention, care-seeking behavior, trust in professionals, and more.
Skin cancer risk classification lacks reliability for darker skin tones and fails in evaluating cutaneous medical conditions or cosmetic interventions, according to creators of the scale.
While 84% of commercials targeted female consumers and 77% utilized celebrity influence, less than half mentioned specific ingredients in skin lightening products.
A prebiotic cleanser and moisturizer regimen not only significantly alleviated the severity of atopic dermatitis and xerosis, but also uncovered crucial differences in symptom experiences.
In one study, less than 5% of images from a HAM10000 database came from patients with darker skin types.
Individuals in Uyo, Nigeria, with albinism are at great risk of developing photodermatoses due to a lack of photoprotection and awareness of photoprotective behaviors.
Adopting diversity management is not just a choice but a pressing need in the evolving health care landscape.
Tapinarof cream 1% has proven to be an effective and safe treatment for atopic dermatitis in diverse populations, according to a poster presented at the SPD's annual meeting.
Researchers noted how historical bias in dermatology research has impacted the understanding and treatment of conditions in darker skin.
Topical corticosteroids are the gold standard treatment for VLS, yet women with skin of color are not represented in studies.
Melasma, challenging due to varied pigmentation in different skin types, requires personalized, tailored care.
An Australian study reviewed appropriate terminology, gender affirming options, and dermatological considerations in caring for gender-diverse patients.
Kindred spoke with Dermatology Times to discuss AbbVie's recent Science of Skin event and improving access to equitable dermatological care.
Brenda Kong-Tunac, a patient with PsO, PsA, and skin of color, shared her experiences.
Omer Ibrahim, MD, discussed the nuances of aesthetic procedures for patients with skin of color and the importance of tailored treatments, safety, and improved clinician education.
In a review, researchers reported that ethnicity plays a role in outcomes, presentations, and more for individuals with systemic sclerosis.
Researchers identified mistrust, social stigma, and language barriers as major obstacles for ethnic minorities in skin research.
Researchers reported that second-year students were more likely to identify dermatological conditions, particularly in White patients.
The IL-13 inhibitor, FDA-approved for moderate to severe AD, reached all primary endpoints in the study focusing on patients with skin of color.
Researchers analyzed APPs treatment and perceptions on AD in studies focusing on patient satisfaction and patients with skin of color.
Zelma Chiesa Fuxench, MD, MSCE, FAAD, and Mona Shahriari, MD, FAAD, discussed the lack of research into psoriasis in skin of color, the absence of diversity in clinical trial populations, and where dermatology as a discipline can go from here.
After releasing promising data from several clinical trials, Burnett discussed the importance of studying efficacy and safety across diverse populations.
A review found clinical trials for HS lack diversity, limiting understanding of treatment efficacy for SOC populations.
Historically, research and clinical practice often have overlooked the distinct manifestations and treatment needs of patients with skin of color who have psoriasis.
Bree Vanleeuwen, PA-C, and Jim Sutton, PA-C, discussed the Skin Cancer Awareness project—a unique initiative to train cosmetologists and hairdressers to recognize suspicious skin lesions and refer clients for dermatologic evaluation.
The study demonstrated significant reductions in inflammatory and non-inflammatory lesions for Hispanic patients using CAB gel.
The study called for improved diversity in clinical training materials to help future clinicians better recognize conditions on darker skin.
Dena Antowan shared her journey balancing pre-med life, managing HS, advocating on TikTok, and her vision for empathetic dermatologic care.
Researchers noted higher correlations in those who are prone to severe acne and post acne erythema (PAE).
The effect of insurance status on US patients with psoriasis can help identify those at risk of being undertreated.
Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplements each month.